Enanta Pharmaceuticals
ENTA
ENTA
130 hedge funds and large institutions have $416M invested in Enanta Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
8% more funds holding
Funds holding: 120 → 130 (+10)
2.59% more ownership
Funds ownership: 88.83% → 91.43% (+2.6%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
130
Holding in Top 10
1
Calls
$2.09M
Puts
$25K
Top Buyers
| 1 | +$24.9M | |
| 2 | +$22.6M | |
| 3 | +$15.8M | |
| 4 |
KAM
Krensavage Asset Management
New York
|
+$8.28M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$8.26M |
Top Sellers
| 1 | -$9.58M | |
| 2 | -$3.53M | |
| 3 | -$2.6M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.02M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$1.52M |
